Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This combination consists of four traditional catecholamine inotropic and vasopressor agents: adrenaline (epinephrine), noradrenaline (norepinephrine), dopamine, and dobutamine. These agents are used perioperatively to support cardiac output and maintain hemodynamic stability in patients with low ejection fraction (typically <35%) undergoing cardiac surgery, such as coronary artery bypass grafting (CABG) or valve surgery. Adrenaline and noradrenaline act on alpha- and beta-adrenergic receptors to increase heart rate, contractility, and systemic vascular resistance. Dopamine acts on dopaminergic and adrenergic receptors in a dose-dependent manner, while dobutamine is a synthetic catecholamine that primarily targets beta-1 adrenergic receptors to enhance myocardial contractility. In clinical research, this combination is often used as a standard-of-care comparator against newer agents like levosimendan.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on adrenaline + noradrenaline + dopamine + dobutamine.